You just read:

AcelRx Pharmaceuticals to Present Initial Results of Phase 3 Study of ARX‑04 at World Congress of Mountain & Wilderness Medicine

News provided by

AcelRx Pharmaceuticals, Inc.

01 Aug, 2016, 07:00 ET